By
Drug Target Review2025-09-02T08:30:47
Researchers have tested a new cancer drug in pet cats with head and neck squamous cell carcinoma – a disease notoriously hard to treat. The trial showed the therapy controlled cancer in 35 percent of cats with minimal side effects – and it could help to treat humans too.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-11T12:59:00Z
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-07-04T10:05:58
Sponsored by Revvity
2026-06-24T13:00:00 2026-06-24T14:00:00
Sponsored by HUB Organoids
2023-05-30T13:51:56
Sponsored by BPS Bioscience
2023-12-11T10:49:07
Sponsored by Leica Microsystems
Site powered by Webvision Cloud